Advertisement

Topics

Cardiogenesis Corp. Company Profile

05:31 EST 19th November 2017 | BioPortfolio


News Articles [35 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

ANN ARBOR, Mich., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today ...

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

ANN ARBOR, Mich., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, to...

Emblem Corp. Appoints Nick Dean as Chief Executive Officer

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSX-V:EMC) (EMC.WT) (“Emblem” or ...

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today...

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

ANN ARBOR, Mich., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today ...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Cited4 is related to cardiogenic induction and maintenance of proliferation capacity of embryonic stem cell-derived cardiomyocytes during in vitro cardiogenesis.

Cardiac progenitor cells have a limited proliferative capacity. The CREB-binding protein/p300-interacting transactivator, with the Glu/Asp-rich carboxy-terminal domain (Cited) gene family, regulates g...

Ronin Governs Early Heart Development by Controlling Core Gene Expression Programs.

Ronin (THAP11), a DNA-binding protein that evolved from a primordial DNA transposon by molecular domestication, recognizes a hyperconserved promoter sequence to control developmentally and metabolical...

Conserved signaling mechanisms in Drosophila heart development.

Signal transduction through multiple distinct pathways regulates and orchestrates the numerous biological processes comprising heart development. This review outlines the roles of the FGFR, EGFR, Wnt,...

Genetic Origins of Tetralogy of Fallot.

Due to improved survival and clinical outcomes, congenital heart disease is an area of growing importance within the medical community. As these patients reach adulthood and have children, there has b...

Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5.

Transcription factors are pivotal regulators of gene transcription, and many diseases are associated with the deregulation of transcriptional networks. In the heart, the transcription factors GATA4 an...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study

The purpose of this study it to collect real world 30-day and 1-year follow-up data for patients undergoing TMR with the CardioGenesis Holmium:YAG Laser System either as a sole therapy pro...

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [40 Associated Companies listed on BioPortfolio]

Cardiogenesis Corp.

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

Cardiogenesis Corporation

Global leader in TMR and PMR (International markets only) An innovative and leading angiogenesis device company providing products that stimulate cardiac angiogenesis Developer of innovative technol...

More Information about "Cardiogenesis Corp." on BioPortfolio

We have published hundreds of Cardiogenesis Corp. news stories on BioPortfolio along with dozens of Cardiogenesis Corp. Clinical Trials and PubMed Articles about Cardiogenesis Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardiogenesis Corp. Companies in our database. You can also find out about relevant Cardiogenesis Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record